
Corporate M&A
Private Equity
Securities Law
Andrew Marmer is a partner in the Corporate and Financial Services Department at Willkie Farr & Gallagher LLP, based in New York. With a focus on mergers and acquisitions, private equity transactions, and SPAC-related matters, Andrew brings extensive expertise in corporate and securities law. He has represented clients across various industries, including financial services, technology, and healthcare. Andrew holds a JD from New York University School of Law and a BA from Vassar College. His career at Willkie Farr & Gallagher has seen him rise from associate to partner, reflecting his dedication and skill in navigating complex legal challenges.
Corporate and M&A Transactions
Private Equity and Portfolio Company Sales
SPAC and IPO Transactions
Securities and Financing Transactions

- 21shares sold the stake/assets to FalconX as part of an acquisition on an undisclosed date. - Deal value was 2400000000 (source: AI Estimation) Sector: Cryptocurrency; Location: Global. - On the seller side, legal advice was provided by a team including David Boston, Samir Patel, Andrew Marmer, and Brandt Dietry.
Dec 04 2025
2B
M&A

Partner
2024 – Unknown
Associate
2017 – 2024
Law Clerk
2016 – 2017
Summer Associate
2015 – 2015
Summer Law Clerk

- CorMedix Inc. acquired the target/assets from selling shareholders in an acquisition. Date of the transaction is not available. - Deal value was 300000000. Sector: Biopharmaceuticals; Location: USA. - On the acquirer side, legal representation details are not available, but the team included Jared Fertman, Andrew Marmer, Theodore Witt, Autri Saha, William Sobel, Jerolynn Liu, Emma Danziger, Akarshana Premanand, Sean Ewen, Marissa Dressor, Qingqing (Chelsea) Zheng.
Aug 11 2025
300M
M&A
Mar 15

1 min
2014 – 2014
Financial Institution Specialist
2012 – 2013
Financial Management Scholar
2011 – 2011
Sports Information Student Assistant
2008 – 2012